Keigo Gohda

Title: Keigo Gohda: Innovator in Cancer Recurrence Risk Assessment

Introduction

Keigo Gohda is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of medical technology, particularly in assessing the risk of cancer recurrence. His innovative approach combines biological data with computational analysis to improve patient outcomes.

Latest Patents

Gohda holds a patent for a "Method for judging risk of cancer recurrence, computer program, and computer system." This method involves acquiring activity values and expression levels of cyclin-dependent kinases (CDKs) from cancer patients' tissues. It also includes assessing the number of Ki67-expressing cells to evaluate the risk of cancer recurrence. The patent highlights the importance of integrating biological markers with computational tools to enhance cancer prognosis.

Career Highlights

Keigo Gohda is associated with Sysmex Corporation, a company known for its advancements in medical diagnostics. His work focuses on developing innovative solutions that aid in cancer treatment and monitoring. Gohda's expertise in both biology and technology positions him as a leader in his field.

Collaborations

Gohda collaborates with esteemed colleagues such as Masaki Shibayama and Hideki Ishihara. Their combined efforts contribute to the development of cutting-edge technologies in cancer research and diagnostics.

Conclusion

Keigo Gohda's contributions to cancer recurrence risk assessment exemplify the intersection of innovation and healthcare. His patented methods and collaboration with industry experts continue to pave the way for advancements in cancer treatment.